Heterocyclic organic compounds

Details for Australian Patent Application No. 2007299870 (hide)

Owner Novartis AG Xenon Pharmaceuticals, Inc.

Inventors Sun, Shaoyi; Fu, Jianmin; Dales, Natalie; Sviridov, Serguei; Kamboj, Rajender; Pokrovskaia, Natalia; Zhang, Zaihui

Agent Davies Collison Cave

Pub. Number AU-A-2007299870

PCT Pub. Number WO2008/036715

Priority 60/826,627 22.09.06 US

Filing date 19 September 2007

Wipo publication date 27 March 2008

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 March 2009 PCT application entered the National Phase

  PCT publication WO2008/036715 Priority application(s): WO2008/036715

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299873-miR-143 regulated genes and pathways as targets for therapeutic intervention

2007299847-Visualizing formation of ablation lesions